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Objective: To determine whether anterior knee pain (AKP), during running, acutely affects lower-
extremity electromyography (EMG) and articular cartilage metabolism.
Methods: A within-subjects design was used. Each of 12 able-bodied subjects ran on a treadmill for
30 min for three different sessions: control (no infusion), sham (0.9% NaCl infusion into the involved-leg
infrapatellar fat pad), and pain (5.0% NaCl infusion into the involved-leg infrapatellar fat pad). Bilateral
surface EMG was monitored for the vastus medialis (VM), vastus lateralis (VL), and gastrocnemius (GA).
Serum cartilage oligomeric matrix protein (COMP) concentration was determined before, after, and
60 min after the run. A functional analysis approach was used to compare EMG amplitude, across the
entire stance phase, between sessions and legs. Mixed-model analysis of covariance was used to compare
serum COMP concentration between sessions, across time.
Results: Relative to the uninvolved leg, greater involved-leg VL and GA EMG amplitude existed during
midstance for the sham and control sessions (P < 0.01). During the painful session, however, involved-leg
VM, VL, and GA EMG amplitude was 5e10% less than for the uninvolved leg. COMP concentration
immediately post-run was 14% and 21% greater than pre-run (P ¼ 0.01) and 60 min post-run concen-
trations (P < 0.01), respectively. Session, however, did not signiﬁcantly inﬂuence COMP.
Conclusion: During a 30-min run, AKP acutely alters midstance VM, VL, and GA EMG amplitude. AKP
during a 30-min run does not, however, acutely inﬂuence articular cartilage metabolism.
© 2014 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Knee pathology and the associated pain is common; 600,000
total knee arthroplasties were performed in the United States in
20101. Cram et al.1 estimated that arthroplasty, alone, cost the
Unites States 9 billion dollars in 2009, and that 3million procedures
will be performed annually by 20302. Although signs and symp-
toms of knee pathologies vary, pain is a chief symptom3. Knee painW.M. Denning, 1435 Village
84408, USA. Tel: 1-801-626-
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ternational. Published by Elsevier Lhas even been described as a musculoskeletal epidemic4. Knee
pathology and the associated pain are especially common for dis-
tance runners. Although distance running has not been directly
linked to a particular knee injury, as many as 79% of all distance
runners become injured and 50% of these injuries are knee in-
juries5. Combining all running injures, 42% affect the knee, and
anterior knee pain (AKP) is associated with 62% of these knee
injuries6.
AKP is associated with abnormal lower-extremity muscle acti-
vation characteristics7e9. Lower-extremity activation characteris-
tics inﬂuence knee joint load, and the activation characteristics for
the vastii and gastrocnemius (GA) are especially inﬂuential on knee
load10,11. AKP is also associated with abnormal lower-extremity
kinematics12e14. Small changes in kinematics can inﬂuence knee
load10. Because AKP causes neural alterations, and because articular
cartilage is sensitive to lower-extremity kinematics15e17 and the
resulting mechanical conditions18,19, AKP likely affects articulartd. All rights reserved.
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articular cartilage condition is affected. In felines, knee joint
degeneration can begin to occur, as a direct result of decreased
muscle force during cyclical loading, in as little as 30 min20. An
experimental AKP model that allows researchers to acutely pro-
duce AKP in otherwise able-bodied subjects could allow re-
searchers to evaluate potential acute effects of AKP on articular
cartilage, independent of other potentially confounding knee pa-
thology factors (e.g., knee joint effusion or degradation)14,21.
Cartilage oligomeric matrix protein (COMP) is a noncollagenous
extracellular matrix protein that is synthesized by chondrocytes
and helps maintain the collagen matrix integrity by binding to type
II collagen ﬁbers; COMP also contributes to the mechanical prop-
erties of articular cartilage and is sensitive to load22e25. COMP is an
established biomarker that reﬂects cartilage metabolism in osteo-
arthritis (OA)26,27 and otherwise injured knee joints28. COMP has
been used to monitor articular cartilage degradation pro-
gress23,29e31. Additionally, COMP concentration increases as a result
of exercise in able-bodied, asymptomatic individuals, which dem-
onstrates that COMP concentration reﬂects normal articular carti-
lage turnover15,32e34. Serum COMP concentration is inﬂuenced by
knee load characteristics15,35, and has also been indirectly related to
muscle activation patterns for lower-extremity muscles during
running32.
The purpose of this study was to determine whether experi-
mental AKP during distance running acutely affects lower-
extremity muscle activation characteristics and articular cartilage
metabolism that results from running. We hypothesized that
experimental AKP during running would decrease muscle activa-
tion for the involved leg, relative to the uninvolved leg. Also, we
hypothesized that experimental AKP during running would enlarge
the increase in serum COMP that is typically associated with
running.Methods
Subjects
Twelve relatively young, able-bodied volunteers (seven males
and ﬁve females; mean ± 1 standard deviation; age ¼ 22 ± 4 years;
mass ¼ 72 ± 28 kg; height ¼ 1.79 ± 0.27 m; body mass
index ¼ 22.2 ± 1.9 kg/m2) were recruited from a university setting.
It was intended that these subjects represent a young able-bodied,
asymptomatic population; free from lower-extremity pathology
and injury. Each subject participated in three different data
collection sessions: pain, control, and sham. No subject reported a
history of lower-extremity injury within 6 months prior to partic-
ipation or any knee surgery in their lifetime. Because physical ac-
tivity habits and body mass index inﬂuence serum COMP
concentration before and after physical activity35, subjects withFig. 1. A description of the general timeline for each data collection session. EMG #1similar physical activity levels were recruited. Each subject was also
required to (1) be participating in moderate physical activity, as
deﬁned by the World Health Organization, at least three times a
week, and (2) have a normal body mass index (between 18.5 and
25). Subjects were required to refrain from exercise between 24 h
prior to the ﬁrst data collection session and the completion of the
ﬁnal data collection session. Prior to participation, subjects
completed an informed consent form that was approved by the
appropriate institutional review board. All study procedures com-
plied with the Helsinki Declaration. We considered sample size, a
priori, using pilot electromyography (EMG) data (EMG being the
most variable) and a multivariate analysis approach. Using this
approach, however, the estimated sample size that was required to
achieve 80% power at a signiﬁcance level of 0.05 was far beyond the
scope of the current study. Consequently, a feasible sample size of
12 subjects was chosen.Experimental protocol
Subjects completed the three different data collection sessions
in a counterbalanced fashion, 48 h apart. For each session, subjects
ran for 30 min on the same treadmill (Quinton Cardiology, Bothell,
WA, USA) at a grade of zero. For the control session, subjects ran on
the treadmill in a typical fashion. For the sham or pain sessions,
subjects ran while receiving a continuous infusion of isotonic (0.9%
NaCl) or hypertonic saline solution, respectively, into the right
(involved) infrapatellar fat pad, at a rate of 0.216 ml min1 (total
infused volume ¼ 8 ml). This pain model (an identical solution
concentration and volume) was used previously to induce consis-
tent and satisfactory experimental AKP levels during running14. For
all data collection sessions, subjects ran in the same pair of their
own running shoes, and running shorts and shirts that were pro-
vided by the investigators.
At the beginning of each data collection session, subjects rested
in a seated position for 30 min to limit potential inﬂuence of pre-
ceding activity on serum COMP concentration. Subjects then stood
for 10 min to allow for body ﬂuid distribution to adjust to the
vertical posture; EMG surface electrodes were applied to the sub-
ject during this standing period. Next, the baseline blood sample
was drawn. Subjects then completed one of three running exer-
cises: control (no infusion), sham (isotonic saline infusion), or pain
(hypertonic saline infusion). A second blood sample was drawn
immediately after the 30-min run. After this blood draw, subjects
rested in a seated position for 60 min, and a ﬁnal blood sample was
then drawn. The general timeline for each session is shown in Fig. 1.
For each data collection session, after the baseline blood sample
was collected and EMG sensors were applied, subjects warmed up
by running on the treadmill at one of three speeds (3.0, 3.5, or
4.0 m/s) for 5 min. The subjects were instructed to select the
greatest of these three speeds that they could run at continuouslyand EMG #2 indicate the times, within the run, that EMG data were collected.
Fig. 2. The knee saline infusion set-up. A pocket (A) that was sewn into the front of a
spandex shirt held the portable syringe pump and syringe. A connection tube (B) was
used to connect the syringe and the catheter (C) that was inserted into the infrapatellar
fat pad.
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sessions. After this 5-min warm-up, subjects lay supine on a
treatment table while the isotonic or hypertonic saline infusions
were initiated, for the sham or pain sessions, respectively. Prior to
these infusions, the skin was shaved, if needed, and prepared with
iodine and an alcohol wipe. The catheter was inserted into the
lateral superior infrapatellar fat pad of the right leg using a previ-
ously described procedure14. After placement, the catheter was
secured with tape, and used a plastic 0.762-m connection tube to
connect the catheter (B. Braun Medical Inc., Melsungen, Germany)
to a portable syringe pump (Graseby Medical Ltd., Watford, En-
gland, UK). Throughout the sham and pain running sessions, this
pump was held in a pocket that was sewn into a spandex running
shirt (Fig. 2). Subjects and investigators were blinded regarding the
saline treatment that was being administered. After the syringe
pump was initiated, subjects lay supine for 3 min, sat upright for
2 min, and then stood for 2 min, in an attempt to familiarize sub-
jects to the experimental AKP and decrease the likelihood of syn-
cope. The subjects then ran for 30 min at the selected speed while
the saline was infused. The control session was identical to the
sham and pain sessions, except that a catheter was not inserted and
no infusion was administered. For each session, a 100-mm visual
analog scale was used to measure subject-perceived AKP immedi-
ately prior to and after the needle stick, and then every 3 min until
60 min after the completion of the run.
EMG
Surface EMG (1000 Hz; Delsys, Boston, MA, USA) was used to
monitor bilateral muscle activation patterns for the GA, vastus
medialis (VM), and vastus lateralis (VL). Previously described rec-
ommendations for skin preparation procedures and electrode
application locations were used36. Thirty seconds of EMG data at
two different times of the run (10 and 20 min after beginning the
run) were collected, and then processed the EMG data using custom
algorithms that were written in MatLab (MathWorks, Natick, MA,
USA). The DC offset was ﬁrst removed and then a root mean square
algorithm (moving window ¼ 50 ms) was applied to rectify and
smooth the EMG signal32. In an effort to minimize the inﬂuence of
electrode placement, the amplitude of the smoothed signal was
then normalized to a reference value that was the average of ten
amplitude peaks from ten different stance phases during thewarm-
up run. Consequently, all EMG amplitude data were reported as a
percentage of this mean peak amplitude (i.e., from the warm-up
run). Also, the EMG signal was time normalized to 100% of the
stance phase, for ﬁve stance phases from 10min after the beginning
of the run and ﬁve stance phases from 20min after the beginning of
the run. Stance phase was manually determined using ten high-
speed video cameras (200 Hz; VICON, Santa Rosa, CA, USA) that
completely surrounded each subject, and reﬂective markers that
were placed bilaterally on the heel and toe. The video and EMG data
were synchronized.
Serum COMP
All blood samples (6 ml) were collected from an antecubital vein
using a 20 gage shielded I.V. catheter (Becton Dickinson & Com-
pany, Franklin Lakes, NJ, USA). Immediately after catheter place-
ment and every 15 min thereafter, the catheter was ﬂushed with
1 ml of isotonic saline (0.9% NaCl) to prevent clotting. A 1 ml waste
sample was drawn before each blood sample was collected. Blood
samples were placed in EDTA vacutainers (Becton Dickinson &
Company, Franklin Lakes, NJ, USA), centrifuged with an Eppendorf
5403 refrigerated centrifuge (Hamburg, Germany) for 15 min at
3,000  gravity, and stored in a freezer at 20C until furtheranalysis. Serum COMP concentration was determined using a
commercially available enzyme-linked immunosorbent assay kit
(ELISA; R&D Systems, Inc., Minneapolis, MN, USA). Serum samples
were analyzed in triplicate across each ELISA plate according to the
manufacturer's instructions. The present ELISA assay kits had inter-
and intra-plate coefﬁcients of variation of 13.66% and 2.61%,
respectively, for a 273.3 ± 33.8 ng/ml sample. Differences due to
inter-plate variation were minimized by comparing serum COMP
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the same plate.
Statistical analysis
The independent variables for this study were session, time, and
leg. The dependent variables were subject-perceived AKP, EMG
amplitude, and serum COMP concentration. We assumed that the
current data would be normally distributed. Prior to statistical an-
alyses, this assumptionwas conﬁrmed viavisual inspection. Another
assumption that our statistical procedure employed, and that we
feel is logical, was that the true EMG functions are continuous (by
true EMG functions we mean that we observed representations of
some underlying EMG over time, whichwewould call the true EMG
functions). A mixed model repeated measures ANOVA was used to
compare subject-perceived AKP between sessions every 3 min
throughout most of each session (Fig. 3; a ¼ 0.05). A mixed model
repeated measures ANOVA was also used to compare serum COMP
concentration between sessions across three times: (1) baseline
(pre-run), (2) immediately post-run, and (3) 1 h post-run (Fig. 1;
a ¼ 0.05). If a session  time interaction was detected for subject-
perceived AKP or serum COMP concentration, Tukey's post hoc
comparisons were used to evaluate potential between-time differ-
ences for each session. Functional linear models were used to eval-
uate inﬂuence of session and leg (involved and uninvolved) on EMG
amplitude, modeled as polynomial functions, across the stance
phase of running. This functional analysis evaluated the effect of
session and leg across all of stance (heel strike to toe-off) in a single
statistical test, rather than using multiple tests at separate discrete
time points within stance, increasing statistical power. For this
particular analysis, differences were signiﬁcant if the mean differ-
ence and corresponding 99% conﬁdence interval (CI) crossed zero.
All ANOVA analyseswere performed using JMP Pro 10 software (SAS
Institute Inc., Cary, NC, USA). The functional linear models were
produced using R statistical software.
Results
Average running speed for the present sample was
3.46 ± 0.43 m/s. A signiﬁcant session  time interaction was
observed for subject-perceived AKP (P < 0.01). Throughout the 30-Fig. 3. Means and 95% CIs for subject-perceived pain across time for each data collection ses
time point). Subject-perceived pain signiﬁcantly increased across time during the pain ses
session was compared to the sham and control sessions.min run, subject-perceived AKPwas signiﬁcantly greater during the
pain session (30 mm, 95% CI: 27, 33), relative to the sham (5 mm,
95% CI: 4, 6) and control sessions (0 mm, 95% CI: 0, 0; Fig. 3). The
subject-perceived AKP signiﬁcantly inﬂuenced EMG amplitude at
various times within stance for all of the observed muscles. No
bilateral EMG amplitude differences larger than 10e14%, however,
were observed. For the control and sham sessions, involved-leg GA
EMG amplitude was 5e10% greater than uninvolved-leg GA EMG
amplitude throughout midstance [P < 0.01; Fig. 4(B, C, E and F)].
Conversely, for the pain session, involved-leg GA EMG amplitude
was 5% less than uninvolved-leg GA EMG amplitude for a short time
around 30% of the stance phase [P < 0.01; Fig. 4(A, D)]. The VM and
VL exhibited similar alterations due to AKP. For VM EMG amplitude,
bilateral symmetry existed for most of the stance phase during the
control and sham sessions [Fig. 5(B, C, E and F)]. For the pain ses-
sion, however, involved-leg VM EMG amplitude was 5e10% less
than uninvolved-leg VM EMG amplitude for much of the middle
part of stance [P < 0.01; Fig. 5(A, D)]. For VL EMG amplitude,
bilateral asymmetries existed for each session, in the same direc-
tion: VL EMG amplitude for the uninvolved leg was ~14%, ~10%, and
~6% greater than for the involved leg during parts of midstance for
the pain, sham, and control sessions, respectively [P < 0.01;
Fig. 6(AeF)]. Time signiﬁcantly inﬂuenced serum COMP concen-
tration as a main effect (P < 0.001; Fig. 7). Average serum COMP
concentration, immediately post-run (132 ng ml1, 95% CI: 94, 170),
was 14% greater than immediately pre-run (116 ng ml1, 95% CI: 78,
154, P ¼ 0.0092) and 21% greater than 60 min post-run
(109 ng ml1, 95% CI: 70, 147; P ¼ 0.0002). Serum COMP concen-
tration was not signiﬁcantly different between pre-run and 60 min
post-run (P ¼ 0.29). No session  time interaction for serum COMP
concentration (P ¼ 0.57; Fig. 7) was observed. Furthermore, as
a main effect, session did not signiﬁcantly affect serum COMP
concentration (P ¼ 0.48). When certain subject characteristics
(running speed, gender, age, and body mass index) were included
as covariates, all of the reported results remained the same
(Appendix A).Discussion
This study was performed to understand whether AKP during
distance running acutely affects lower-extremity muscle activationsion (95% CIs are not included for the control session because they equaled zero at each
sion only (P < 0.01). Asterisks show statistically signiﬁcant differences when the pain
Fig. 4. Grand ensembles (99% CIs are only shown for involved (right) leg to increase clarity) for GA EMG amplitude (Amp), for the pain (A), control (B), and sham (C) sessions. DeF
show results of bilateral functional comparisons, where mean bilateral differences and corresponding 99% CIs are plotted as a function of time. When the shaded area does not
overlap with the zero line, a bilateral difference (P < 0.01) is indicated. Positive differences indicate that involved-leg (right) EMG is greater, while negative differences indicate the
opposite.
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that, relative to pain free running, running for 30 min with AKP
would (1) decrease EMG amplitude for the involved leg, relative to
the uninvolved leg, and (2) enlarge the serum COMP concentration
increase that typically results from running. The present results
supported the ﬁrst hypothesis, but did not support the second
hypothesis: EMG amplitudes for the involved leg (for muscles that
signiﬁcantly inﬂuence knee joint load) were decreased, relative to
the uninvolved leg, during AKP running; however, pain free and
painful running had similar effects on serum COMP concentration.
The observed EMG alterations are important ﬁndings from this
study. Although knee load was not directly measured, the present
decreases for GA, VM, and VL EMG amplitude that were due to AKP
likely indicate altered knee load: muscle forces signiﬁcantly and
directly impact tibial-femoral contact load10,20,37. Speciﬁcally, vastiiFig. 5. Grand ensembles (99% CIs are only shown for involved (right) leg to increase clarity)
show results of bilateral functional comparisons, where mean bilateral differences and cor
overlap with the zero line, a bilateral difference (P < 0.01) is indicated. Positive differences in
opposite.and GA activity inﬂuence knee load during the stance phase of
human locomotion10,11. Although it is admittedly difﬁcult to
determine whether EMG differences of 10e14% are clinically
meaningful, the observed reduction for VM EMG amplitude likely
contributes to abnormal patellar tracking within the trochlear
groove38,39. This idea is congruent to the clinical treatment of AKP
in young adults that is strengthening the oblique VM40. Further, the
present statistical analyses of EMG involved CIs, which are one way
to evaluate clinical signiﬁcance41. Whenever present CIs did not
cross the zero line (Figs. 4e6), the described differences can be
considered as clinically signiﬁcant41.
Normal knee joint load that (1) results from lower-extremity
muscle force and (2) is required to perform everyday function is
important to maintain articular cartilage. For example, reduced
quadriceps strength has been linked to symptomatic andfor VM EMG amplitude (Amp), for the pain (A), control (B), and sham (C) sessions. DeF
responding 99% CIs are plotted as a function of time. When the shaded area does not
dicate that involved-leg (right) EMG is greater, while negative differences indicate the
Fig. 6. Grand ensembles (99% CIs are only shown for involved (right) leg to increase clarity) for VL EMG amplitude (Amp), for the pain (A), control (B), and sham (C) sessions. DeF
show results of bilateral functional comparisons, where mean bilateral differences and corresponding 99% CIs are plotted as a function of time. When the shaded area does not
overlap with the zero line, a bilateral difference (P < 0.01) is indicated. Positive differences indicate that involved-leg (right) EMG is greater, while negative differences indicate the
opposite.
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lower-extremity muscle force during cyclical loading has been
associatedwith joint degeneration in as little as 30min20. To date, it
remains unclear if experimental AKP can inﬂuence the onset and/or
progression of articular cartilage degradation. Further research is
required to investigate the potential effect of persistent experi-
mental AKP (>30 min) on EMG and serum COMP concentration.
The present ﬁndings suggest that AKP alters neuromuscular
activation patterns. Previously, researchers have theorized that AKP
is a result of altered neuromuscular activation patterns43,44. The
present data indicate that the reverse is also true: altered EMG
patterns result from AKP. Additionally, bilateral EMG data from the
present control session demonstrated subtle asymmetries for
neural activation for the GA, VM, and VL muscles during able-
bodied running (Figs. 4e6). This ﬁts with previous researchFig. 7. Means and 95% CIs for serum COMP concentration at three times for each sessio
immediately post-run, relative to pre-run and 60 min post-run; this trend was consistent bdocumenting lower-extremity EMG asymmetries for the GA, VM,
and VL muscles during able-bodied walking45,46. While attempting
to interpret the present EMG data, we were surprised to learn that
no one has previously evaluated bilateral symmetry for EMG during
able-bodied running, especially using the relatively novel statistical
approach (functional linear models) that was presently used. Like
other previously published EMG data, the reliability of the present
EMG data is limited due to numerous issues that are inherent to
EMG (e.g., varying electrode placement, muscle ﬁber length, and
contraction velocity). However, efforts were made to minimize
such limitations where possible (e.g., normalization of EMG
amplitude).
The present COMP data and data from previous re-
searchers15,16,33,34, demonstrate that the magnitude and duration
of serum COMP concentration increase, due to physical activity, isn. If pooled from each session, serum COMP concentration was signiﬁcantly greater
etween sessions.
Pre-run Post-run 60 min post-run
Control 108.7 (65.3e152.2) 125.6 (82.1e169.1) 97.1 (53.7e140.6)
Sham 112.9 (69.5e156.4) 132.2 (88.7e175.6) 109.5 (66.0e1 52.9)
Pain 120.2 (76.7e163.6) 132.5 (89.1e176.0) 112.5 (69.0e155.9)
Average 113.9 (71.1e156.7) 130.1* (87.3e172.9) 106.4 (63.6e149.2)
*Signiﬁcantly different (P < 0.05) from pre-run and 60 min post-run concentration.
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serum COMP concentration increases 90% and 60% as a result from
a 200-km ultramarathon and marathon33, respectively, while only
a 9.7% serum COMP concentration increase resulted from a less
intense 30-min walk35. The present observation of a 14% increase
for serum COMP concentration (Fig. 7), resulting from a 30-
min run, ﬁts with these previously reported data. Additionally,
walking for 30 min resulted in an increased COMP concentration
duration of 30 min35, while running durations of 30 min16,
3e4 h34, and 3e33 h33 resulted in elevated COMP concentration
for 1 h, 24 h9, and 6 days, respectively. Fitting with previous re-
sults15,16, the present COMP concentration returned to baseline
levels within 1 h (Fig. 7). It appears that exercise sessions
involving greater durations and intensities, and greater cumulative
knee load, elicit greater amounts of COMP released from articular
cartilage.
Interpretation of increased COMP, as a result of exercise, is un-
clear. Although some authors have hypothesized that elevated
COMP concentration may indicate detrimental articular cartilage
degradation15,34, other authors have speculated that increased
COMP concentration represents typical, healthy articular cartilage
turnover16,33. Previously, researchers15,32,35 have demonstrated
that as serum COMP concentration increases, articular cartilage
volume decreases, even in a healthy population. Kim et al.33 spec-
ulated that running distance and the corresponding magnitude and
duration of COMP concentration increase may each be positively
correlated with the degree of articular cartilage damage. It is
assumed that the presently observed COMP concentration in-
creases reﬂected healthy articular cartilage turnover. The present
subjects ran, on average, only 6.2 Km, and COMP levels increased
only 14% and returned to pre exercise levels in less than 60 min
(Fig. 7). The present data are limited to a single running session, and
more data are needed to determine the chronic effects of AKP on
articular cartilage health.
The use of this experimental AKPmodel to understand effects of
pain on articular cartilage is another novel feature of this study. This
pain model was presently used to induce consistent experimental
AKP during a 30-min run (Fig. 3). This 30-min duration is nearly
70% greater than the previous longest duration14. For this reason,
the present results further demonstrate that this pain model can be
used to study independent effects of AKP during various exercises
over relatively extended durations. As with any novel method,
however, certain aspects related to the present AKP model are
unclear. Although the magnitude of subject-perceived AKP (Fig. 3)
appears to have been sufﬁcient to represent clinical AKP47, it is
unclear whether other characteristics of this AKP pain are clinically
representative. However, previous researchers propose that
experimental pain, induced by hypertonic saline, is representative
of joint pain related to knee pathology21,48e50. The nature, quality,
and distribution of pain elicited by hypertonic saline have been
shown to be similar to clinical AKP21. Also, results from animal
experiments suggest that group III and IV nociceptive afferents are
active due to hypertonic saline49,50, providing more evidence that
the pathways involved during this experimental pain are similar to
musculoskeletal pain. Furthermore, hypertonic saline induces the
release of substance P from C-ﬁber neurons, which is also consis-
tent with musculoskeletal pain48.
In conclusion, there are three important ﬁndings from this
study. First, experimental AKP generally caused involved-leg EMG
amplitude to decrease, during running, relative to uninvolved-leg
EMG amplitude (Figs. 4e6). Second, experimental AKP did not
signiﬁcantly affect systemic serum COMP concentration increase
due to running (Fig. 4). Third, the infusion of hypertonic saline
effectively produced consistent subject-perceived AKP throughout
a 30-min run (Fig. 3).Author contributions
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Appendix A
Average (95% CI) serum COMP concentration (ng ml1) when
running speed, gender, age, and body mass index were used as
covariates. None of the covariates included in this model were
statistically signiﬁcant. Neither running speed (P ¼ 0.55), gender
(P¼ 0.63), age (P¼ 0.71), nor bodymass index (P¼ 0.50) inﬂuenced
serum COMP concentration. Time was the only signiﬁcant main
effect that inﬂuenced serum COMP (P < 0.001).References
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